| Source of Funding | FY 2001 Actual | FY 2002 Estimate | FY 2003 Estimate |
|---|---|---|---|
| Appropriation |
$786,039,000
|
$893,443,000
|
$950,150,000
|
| Enacted Rescission |
(285,000)
|
(313,000)
|
---
|
| Subtotal, Adjusted Appropriation |
785,754,000
|
893,130,000
|
950,150,000
|
| Comparable adjustment for legislative proposal for accrued retirement costs |
2,711,000
|
2,934,000
|
3,010,000
|
|
Real transfer to: Other HHS Agencies through Secretary's one-percent transfer authority |
(149,000)
|
---
|
---
|
| Real transfer to HHS for the Office of Human Research Protection |
(164,000)
|
---
|
---
|
|
Comparative transfer from: Office of the Director for the Academic Research Enhancement Award program |
862,000
|
---
|
---
|
| National Cancer Institute for research activities |
---
|
---
|
18,549,000
|
| Comparative transfer to: National Institute of Biomedical Imaging and Bioengineering |
(247,000)
|
---
|
---
|
|
Subtotal
|
788,767,000
|
896,064,000
|
971,709,000
|
| Subtotal, adjusted budget authority |
788,767,000
|
896,064,000
|
971,709,000
|
| Unobligated balance, lapsing |
(28,000)
|
---
|
---
|
|
Total obligations
|
788,739,000
|
896,064,000
|
971,709,000
|
Excludes the following amounts for reimbursable activities carried out by this account:
FY 2001 - $1,101,000; FY 2002 - $1,101,000; FY 2003 - $1,101,000.
Excludes $395,000 in FY 2001 and $395,000 in FY 2002 for royalties.
